Our Chief Scientific Officer Laura Sepp-Lorenzino, Ph.D., will speak on “Realizing the Promise of In Vivo CRISPR Therapeutics” at the Controlled Release Society 2024 Annual Meeting and Exposition in Bologna, Italy, on July 12. Details here: https://lnkd.in/gNgW-eZm #geneediting #CRISPR
Intellia Therapeutics, Inc.’s Post
More Relevant Posts
-
So amazing how fast antibody production can be! As their catch phrase goes, Biointron can certainly help with accelerating your antibody discovery. https://lnkd.in/gbgdjSYe
To view or add a comment, sign in
-
VP of Sales and Support, Scale Bio. Passion for Science, growing and leading teams, let's drive results
Did you miss our Webinar on how to Scale up your CRISPR Screening projects? Watch on-demand where Single Cell Discoveries did a 1M scCRISPR project. Check it out: https://lnkd.in/eyGrj99H
CRISPR Screening at Scale - Scalebio
https://scale.bio
To view or add a comment, sign in
-
SFBN Feed: Illuminating the dance of the messenger https://lnkd.in/gmGgiVC3 A new method for unlocking the secrets of RNA using ultrabright X-rays has implications for understanding diseases and designing therapeutics. Click here to view original post #BayArea #SanFrancisco #Biotech #Lifescience #News
Illuminating the dance of the messenger
https://sfbn.org
To view or add a comment, sign in
-
Need differentiated cells on your iPSC patient specific lines? Or do you have a unique line that poorly differentiates with your own protocol and you need help? If you face such challenges let Trailhead assist - this is one way where the power of HD-DoE can help. #ipsc #pluripotent #stemcell #drugdiscovery #trailbio #hddoe #cellmanufacturing #biomanufacturing #qbd #designofexperiments
At Trailhead Biosystems, we understand that groundbreaking research demands more than just off-the-shelf cell products. Our team of expert scientists can help turn your iPSC lines into your desired cell type through our proprietary protocols. Our customized solutions are designed to meet your unique needs, including... ✅ Higher purity for disease modeling ✅ Improved functionality for drug screening ✅ Large-scale production for regenerative medicine applications With state-of-the-art facilities and an unwavering commitment to quality, we ensure the reliable generation of the desired cell types, empowering you to unlock new avenues in your research. Explore our differentiation services to learn more about our tailored offerings and how we can support your pioneering work in disease modeling, drug discovery, and regenerative medicine. https://lnkd.in/gkEbXXtA #trailhead #trailbio #ipsc #stemcell #differentiation #ipscdifferentiation #diseasemodeling #production #manufacturing #solution #research
Custom iPSC Differentiation | Trailhead Biosystems
https://trailbio.com
To view or add a comment, sign in
-
CRISPR-Cas9 is a powerful tool to interrogate gene function in a targeted and systematic manner. Although the technology has been scaled up for large-scale genetic screens in cell culture, similar scale screens in vivo have been extremely challenging due to the cost, labor, and time required to generate and keep track of thousands of mutant animals. We reported the development of Multiplexed Intermixed CRISPR Droplets (MIC-Drop), a platform that makes large-scale reverse genetic screens possible in zebrafish. In this webinar, we will share the details of this technique and discuss best practices for performing MIC-Drop screens in zebrafish. The speakers will discuss: · Steps to successfully perform a large-scale CRISPR screen in zebrafish using the MIC-Drop platform · Possible directions to expand the applicability of MIC-Drop Speaker Saba Parvez Saba Parvez, Ph.D. Postdoctoral fellow, Department of Pharmacology & Toxicology, University of Utah, Salt Lake City, UT
MIC-Drop- a platform for large-scale in vivo CRISPR screens
bio-protocol.org
To view or add a comment, sign in
-
EditCo Bio & Saha Lab Collaboration Breakdown: The study demonstrates the efficient production of primary human T cells with simultaneous CRISPR/Cas9-mediated knockout of three genes (B2M, TRAC, PD1) and non-viral transfection of a CAR targeting GD2. The resulting TRAC-B2M-PD1-deficient GD2 CAR T cells show high cytotoxicity against neuroblastoma cells, retain a central memory phenotype, and exhibit low off-target effects and chromosomal alterations. This approach highlights the potential for rapid, safe, and efficient manufacturing of potent allogeneic CAR T-cell products.
To view or add a comment, sign in
-
"Regarding vaccine development...and the role my team plays in the development of #cryoEM technology, we see the study and dissemination of virus structures, and the proteins that comprise them, as vital to vaccine design," says my colleague Melanie Adams-Cioaba in a Q&A with Drug Discovery World. Check out the full interview in the spring issue today!
DDW SPRING 2024 | How Structural Biology is Informing Vaccine Design
https://flippingbook.com/
To view or add a comment, sign in
-
"Regarding vaccine development...and the role my team plays in the development of #cryoEM technology, we see the study and dissemination of virus structures, and the proteins that comprise them, as vital to vaccine design," says my colleague Melanie Adams-Cioaba in a Q&A with Drug Discovery World. Check out the full interview in the spring issue today!
DDW SPRING 2024 | How Structural Biology is Informing Vaccine Design
https://flippingbook.com/
To view or add a comment, sign in
-
"Regarding vaccine development...and the role my team plays in the development of #cryoEM technology, we see the study and dissemination of virus structures, and the proteins that comprise them, as vital to vaccine design," says my colleague Melanie Adams-Cioaba in a Q&A with Drug Discovery World. Check out the full interview in the spring issue today!
DDW SPRING 2024 | How Structural Biology is Informing Vaccine Design
https://flippingbook.com/
To view or add a comment, sign in
-
The next big advancement in CITE-seq technology is coming soon. Expand the power of CITE-seq to beyond the cell surface ! The countdown begins for a complete and validated solution to detect RNA and surface + intracellular proteins ! In the meantime, check out our single cell multiomics solutions at https://lnkd.in/e84Z8cA9. #SingleCellAnalysis #BDBiosciences #SingleCellMultiomics For Research Use Only. Not for use in diagnostic or therapeutic procedures.
To view or add a comment, sign in
-
Very exited whith yours overcome news!